CEO LEADERSHIP SERIES
ASHTON TWEED'S CEO INTERVIEWS
April 14, 2016
TAKING THE REINS OF A HEALTHCARE TECHNOLOGY INVESTMENT COMPANY French by birth, based in London and doing business in the San Francisco Bay-area biotech community, Dr. […]
March 17, 2016
PASSION FOR PATIENT CARE HELPS BUILD BUSINESS As the CEO of Orthotic Holdings Inc. (OHI), Ivan R. Sabel draws on his experience as both a practitioner […]
January 29, 2016
MAKING CONNECTIONS AND SEIZING OPPORTUNITIES Kathleen P. DeLawrence, Chief Operating Officer of Ability Prosthetics & Orthotics, Inc., has an impressive breadth of experience in the pharmaceutical, […]
December 9, 2015
AFTER DECADES AT MERCK, A NEW ENTREPRENEURIAL BEGINNING After 26 years at Merck & Co. Inc., Graham G. Lumsden was evaluating his career options. He decided […]
October 28, 2015
FROM BIG PHARMA LAYOFF TO LAUNCHING A CRO When Renold J. Capocasale learned that he was being laid off by Johnson & Johnson, where he had […]
September 21, 2015
FROM SEED FUNDING TO FDA APPROVAL IN 20 MONTHS! The biopharmaceutical industry was abuzz earlier this month with the long-awaited launch of Sandoz’ Zarxio™ (filgrastim-sndz), the […]
August 12, 2015
TRANSITIONING FROM SCIENTIST TO CEO By the time he co-founded PDS Biotechnology Corp., a clinical-stage biotech company in North Brunswick, N.J., Dr. Frank K. Bedu-Addo had […]
June 28, 2015
HOW TO REINVENT YOURSELF IN TURBULENT TIMES David Owens is an expert on reinvention and the unconventional path to the C-suite. In 2009, after 30 years in […]
May 15, 2015
THE IMPORTANCE OF BUILDING A STRONG BOARD OF DIRECTORS The composition of a company’s board of directors ultimately can make or break a business. Warren Cooper, […]
September 4, 2014
PRIVATE VS. PUBLIC COMPANY LEADERSHIP “To be successful as a chief executive officer, you have to know how to run an enterprise. You have to be […]
April 17, 2014
MAKING A SMOOTH TRANSITION FROM A LARGE MEDICAL DEVICE FIRM TO A SMALL BIOPHARMACEUTICAL COMPANY Last year, David Johnson made a big change in his career […]
September 1, 2012
USING VIRTUAL BIOTECHS TO MOVE DRUGS INTO DEVELOPMENT MORE EFFICIENTLY This year, Bridgewater, NJ-based Drais Pharmaceuticals, Inc., has launched a new business model. According to Drais […]
June 1, 2012
SUCCESS STRATEGIES FOR NEW DRUG DEVELOPMENT TODAY Originally published in Ashton Tweed Connection, Summer 2012 As the former President and CEO of Prism Pharmaceuticals, Dr. Warren […]
April 1, 2012
SUCCESSFULLY RIDING THE WAVE OF CHANGE IN PHARMA TODAY Originally published in Ashton Tweed Connection, April 2012 In 2005, Nick Spring cofounded Topaz Pharmaceuticals — a […]
ARE YOU A CEO INTERESTED IN JOINING OUR LEADERSHIP SERIES?
CONTACT US TO DISCUSS AN INTERVIEW:
Jordan Warshafsky
Partner, Ashton Tweed Ltd.
Email: JWarshafsky@ashtontweed.com
Phone: 610.725.0290 x441
Ashton Tweed, Ltd.
314 S. Henderson Rd.
Suite G370
King of Prussia, PA 19406